Financial statements Drog-Mal
Balance sheet data of DROG-MAL
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
|---|---|---|---|---|---|
| Total assets | 3 914 160,97 | 6 756 176,54 | 6 459 307,92 | 5 140 927,38 | 4 879 789,45 |
| A. Fixed assets | 892 080,67 | 875 690,02 | 1 498 221,61 | 1 302 674,86 | 1 228 311,39 |
| B. Current assets | 3 022 080,30 | 5 880 486,52 | 4 961 086,31 | 3 838 252,52 | 3 651 478,06 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 3 914 160,97 | 6 756 176,54 | 6 459 307,92 | 5 140 927,38 | 4 879 789,45 |
| A. Equity | 1 792 112,87 | 3 242 322,17 | 3 450 817,76 | 3 423 840,40 | 3 906 164,86 |
| B. Liabilities and provisions for liabilities | 2 122 048,10 | 3 513 854,37 | 3 008 490,16 | 1 717 086,98 | 973 624,59 |
| I. Long-term liabilities | 110 607,98 | 72 762,95 | 704 556,47 | 597 267,40 | 179 659,82 |
| II. Short-term liabilities | 1 885 645,37 | 3 363 627,47 | 2 226 469,74 | 1 042 355,63 | 657 115,28 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.